Sarepta Therapeutics (SRPT) Return on Sales (2012 - 2026)
Sarepta Therapeutics' quarterly Return on Sales came in at 0.01% in Q1 2026, up 4.0% year-on-year from 0.01% in Q1 2025, and up 229.31% quarter-over-quarter from 0.01% in Q4 2025.
Sarepta Therapeutics has reported Return on Sales for 13 years, with the latest figure at 0.01% in Q1 2026.
- For the quarter ending Q1 2026, Return on Sales rose 4.0% year-over-year to 0.01%; the trailing twelve-month figure through Mar 2026 stood at 0.0% (changed 0.0% YoY), and the FY2025 full-year result was 0.0%, changed 0.0% from the prior year.
- Return on Sales for Q1 2026 stood at 0.01%, up from 0.01% in the prior quarter.
- The five-year high for Return on Sales was 0.02% in Q4 2022, with the low at 0.05% in Q1 2022.
- Average Return on Sales over 5 years is 0.01%, with a median of 0.0% recorded in 2023.
- Year-over-year, Return on Sales declined 4 bps in 2022 and gained 4 bps in 2026.
- Tracing SRPT's Return on Sales over 5 years: stood at 0.02% in 2022, then slumped by 67 bps to 0.01% in 2023, then tumbled by 84 bps to 0.0% in 2024, then plunged by 731 bps to 0.01% in 2025, then surged by 229 bps to 0.01% in 2026.
- The last three Return on Sales figures came in at 0.01% (Q1 2026), 0.01% (Q4 2025), and 0.0% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.00% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 0.00% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 0.00% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.00% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 0.00% |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn | 0.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.01% |
| Dec 31, 2025 | -0.01% |
| Sep 30, 2025 | 0.00% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | -0.03% |
| Dec 31, 2024 | 0.00% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | 0.00% |
| Dec 31, 2023 | 0.01% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | -0.01% |
| Mar 31, 2023 | -0.02% |
| Dec 31, 2022 | 0.02% |
| Sep 30, 2022 | -0.01% |
| Jun 30, 2022 | -0.01% |
| Mar 31, 2022 | -0.05% |
| Dec 31, 2021 | -0.01% |
| Sep 30, 2021 | 0.00% |
| Jun 30, 2021 | -0.01% |
| Mar 31, 2021 | -0.01% |
| Dec 31, 2020 | -0.08% |
| Sep 30, 2020 | -0.09% |
| Jun 30, 2020 | -0.06% |
| Mar 31, 2020 | -0.01% |
| Dec 31, 2019 | -0.02% |
| Sep 30, 2019 | -0.01% |
| Jun 30, 2019 | -0.03% |
| Mar 31, 2019 | -0.01% |
| Dec 31, 2018 | -0.02% |
| Sep 30, 2018 | -0.01% |
| Jun 30, 2018 | -0.01% |
| Mar 31, 2018 | -0.01% |
| Dec 31, 2017 | 0.00% |
| Sep 30, 2017 | -0.01% |
| Jun 30, 2017 | -0.02% |
| Mar 31, 2017 | 0.05% |
| Dec 31, 2014 | -16.56% |
| Sep 30, 2014 | -0.32% |
| Jun 30, 2014 | -0.12% |
| Mar 31, 2014 | -0.04% |
| Dec 31, 2013 | -0.13% |
| Sep 30, 2013 | -0.06% |
| Jun 30, 2013 | -0.06% |
| Mar 31, 2013 | -0.03% |
| Dec 31, 2012 | -0.01% |
| Sep 30, 2012 | -0.01% |
| Jun 30, 2012 | 0.00% |
| Mar 31, 2012 | -0.01% |